- Filed
- May 7, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 1, 2025 | 118.09M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $1.17B |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $831M |
| Short Term Debt | Q1 2025 · Mar 31, 2025 | $9M |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $5M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $1.15B |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $1.06B |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $783M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $628M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $2.11B |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $1.62B |
| Current Assets | Q1 2025 · Mar 31, 2025 | $1.48B |
| Current Assets | Q1 2025 · Dec 31, 2024 | $1.32B |
| Total Assets | Q1 2025 · Mar 31, 2025 | $2.76B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $2.56B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 138.44M sh |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $139M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $825M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $871M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.43 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.43 |
| Sga Expense restated | Q1 2025 · Mar 31, 2024 | $29M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$59M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$15M |
| Revenue | Q1 2025 · Mar 31, 2024 | $395M |